A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs

被引:0
作者
Frimpong, Jemima A. [1 ]
Parish, Carrigan L. [2 ]
Feaster, Daniel J. [3 ]
Gooden, Lauren K. [2 ]
Nelson, Mindy C. [3 ]
Matheson, Tim [4 ]
Siegel, Karolynn [5 ]
Haynes, Louise [6 ]
Linas, Benjamin P. [7 ]
Assoumou, Sabrina A. [7 ]
Tross, Susan [8 ]
Kyle, Tiffany [3 ]
Liguori, Terri K. [2 ]
Toussaint, Oliene [2 ]
Annane, Debra [9 ]
Metsch, Lisa R. [10 ,11 ]
机构
[1] New York Univ Abu Dhabi, Saadiyat Isl POB 129188, Abu Dhabi, U Arab Emirates
[2] Columbia Univ, Dept Sociomed Sci Miami Res Ctr, 1120 NW 14 St Room 1030, Miami, FL 33136 USA
[3] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, 1120 NW 14th St,Room 1059, Miami, FL 33136 USA
[4] San Francisco Dept Publ Hlth SFDPH, 25 Ness Ave Suite 500, San Francisco, CA 94102 USA
[5] Columbia Univ, Dept Sociomed Sci, 722 West 168 St, New York, NY 10032 USA
[6] Med Univ South Carolina, 67 President St, Charleston, SC 29425 USA
[7] Boston Med Ctr, Crosstown Bldg 801 Massachusetts Ave Off 2007, Boston, MA 02118 USA
[8] Columbia Univ, NYS Psychiat Inst, HIV Ctr Clin & Behav Studies, Irving Med Ctr, 1051 Riverside Dr, New York, NY 10032 USA
[9] Hlth Fdn South Florida, 2 South Biscayne Blvd,Suite 1710, Miami, FL 33131 USA
[10] Columbia Univ, Dept Sociomed Sci, 2970 Broadway,612 Lewisohn Hall, New York, NY 10026 USA
[11] Columbia Univ, Columbia Sch Gen Studies, 2970 Broadway,612 Lewisohn Hall, New York, NY 10026 USA
关键词
HIV; Hepatitis C virus; Practice coaching; Cluster randomized controlled trial; Organizational change; Opioid treatment program; Substance use disorder treatment; C VIRUS-INFECTION; USE DISORDER TREATMENT; UNITED-STATES; COST-EFFECTIVENESS; PRIMARY-CARE; IMPLEMENTATION; SERVICES; BARRIERS; MEN; SEX;
D O I
10.1186/s13063-023-07602-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundPeople with substance use disorders are vulnerable to acquiring HIV. Testing is fundamental to diagnosis, treatment, and prevention; however, in the past decade, there has been a decline in the number of substance use disorder (SUD) treatment programs offering on-site HIV testing. Fewer than half of SUDs in the USA offer on-site HIV testing. In addition, nearly a quarter of newly diagnosed cases have AIDS at the time of diagnosis. Lack of testing is one of the main reasons that annual HIV incidences have remained constant over time. Integration of HIV testing with testing for HCV, an infection prevalent among persons vulnerable to HIV infection, and in settings where they receive health services, including opioid treatment programs (OTPs), is of great public health importance.Methods/designIn this 3-arm cluster-RCT of opioid use disorders treatment programs, we test the effect of two evidence-based "practice coaching" (PC) interventions on the provision and sustained implementation of on-site HIV testing, on-site HIV/HCV testing, and linkage to care. Using the National Survey of Substance Abuse Treatment Services data available from SAMHSA, 51 sites are randomly assigned to one of the three conditions: practice coach facilitated structured conversations around implementing change, with provision of resources and documents to support the implementation of (1) HIV testing only, or (2) HIV/HCV testing, and (3) a control condition that provides a package with information only. We collect quantitative (e.g., HIV and HCV testing at 6-month-long intervals) and qualitative site data near the time of randomization, and again approximately 7-12 months after randomization.DiscussionInnovative and comprehensive approaches that facilitate and promote the adoption and sustainability of HIV and HCV testing in opioid treatment programs are important for addressing and reducing HIV and HCV infection rates. This study is one of the first to test organizational approaches (practice coaching) to increase HIV and HIV/HCV testing and linkage to care among individuals receiving treatment for opioid use disorder. The study may provide valuable insight and knowledge on the multiple levels of intervention that, if integrated, may better position OTPs to improve and sustain testing practices and improve population health.Trial registrationClinicalTrials.gov NCT03135886. Registered on 2 May 2017.
引用
收藏
页数:16
相关论文
共 35 条
  • [1] HIV and hepatitis C coinfection within the CAESAR study
    Amin, J
    Kaye, M
    Skidmore, S
    Pillay, D
    Cooper, DA
    Dore, GJ
    [J]. HIV MEDICINE, 2004, 5 (03) : 174 - 179
  • [2] [Anonymous], 2022, U.S. Statistics
  • [3] [Anonymous], 2014, FINAL RECOMMENDATION
  • [4] [Anonymous], 2018, HIV Infection, Risk, Prevention, and Testing Behaviors among Persons Who Inject Drugs
  • [5] Addressing Barriers to On-site HIV and HCV Testing Services in Methadone Maintenance Treatment Programs in the United States: Findings From a National Multisite Qualitative Study
    Behrends, Czarina N.
    Kapadia, Shashi N.
    Schackman, Bruce R.
    Frimpong, Jemima A.
    [J]. JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2021, 27 (04) : 393 - 402
  • [6] Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection and Sexually Transmitted Infections in Substance Abuse Treatment Programs in the United States
    Bini, Edmund J.
    Kritz, Steven
    Brown, Lawrence S., Jr.
    Robinson, Jim
    Alderson, Don
    Rotrosen, John
    [J]. JOURNAL OF ADDICTIVE DISEASES, 2011, 30 (02) : 98 - 109
  • [7] Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017
    Bull-Otterson, Lara
    Huang, Ya-Lin A.
    Zhu, Weiming
    King, Hope
    Edlin, Brian R.
    Hoover, Karen W.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (06) : 940 - 947
  • [8] Centers for Disease Control and Prevention, NEW HIV DIAGN PEOPL
  • [9] Centers for Disease Control and Prevention, 2023, HIV PEOPL WHO INJ DR
  • [10] Centers for Disease Control and Prevention, 2023, NEW EST REV DECL HEP